Clinical Trial Update: Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab

View source ↗

Summary

This clinical trial update reports on quality of life and psychosocial factors in patients with severe psoriasis after treatment with adalimumab. The study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Psoriasis | Status: COMPLETED | Results posted: 2015-06-11